J.S. Elborn

Research interests

Publications

• Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC)

  The Lancet Respiratory Medicine · 2023 · https://doi.org/10.1016/s2213-2600(23)00093-0

• Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations

  The Lancet Respiratory Medicine · 2021 · https://doi.org/10.1016/s2213-2600(21)00277-0

• Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study

  The Lancet Respiratory Medicine · 2021 · https://doi.org/10.1016/s2213-2600(20)30504-x

• Lung function and microbiota diversity in cystic fibrosis

  Microbiome · 2020 · 10.1186/s40168-020-00810-3

• Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis

  BMC Pulmonary Medicine · 2018 · https://doi.org/10.1186/s12890-018-0638-0

• British Thoracic Society guideline for bronchiectasis in adults

  BMJ Open Respiratory Research · 2018 · https://doi.org/10.1136/bmjresp-2018-000348

• British Thoracic Society Guideline for bronchiectasis in adults

  Thorax · 2018 · https://doi.org/10.1136/thoraxjnl-2018-212463

• Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del

  New England Journal of Medicine · 2017 · 10.1056/nejmoa1709846

• Neutrophil Elastase Activity Is Associated with Exacerbations and Lung Function Decline in Bronchiectasis

  American Journal of Respiratory and Critical Care Medicine · 2017 · https://doi.org/10.1164/rccm.201605-1027oc

• Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research

  European Respiratory Journal · 2017 · https://doi.org/10.1183/13993003.00051-2017

• Neutrophil extracellular traps are associated with disease severity and microbiota diversity in patients with chronic obstructive pulmonary disease

  Journal of Allergy and Clinical Immunology · 2017 · https://doi.org/10.1016/j.jaci.2017.04.022

• European Respiratory Society guidelines for the management of adult bronchiectasis

  European Respiratory Journal · 2017 · https://doi.org/10.1183/13993003.00629-2017

• The EMBARC European Bronchiectasis Registry: protocol for an international observational study

  ERJ Open Research · 2016 · https://doi.org/10.1183/23120541.00081-2015

• Cystic fibrosis

  The Lancet · 2016 · https://doi.org/10.1016/s0140-6736(16)00576-6

• Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR

  New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1409547

• International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety

  Thorax · 2015 · https://doi.org/10.1136/thoraxjnl-2015-207488

• Future trends in cystic fibrosis demography in 34 European countries

  European Respiratory Journal · 2015 · 10.1183/09031936.00196314

• Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial

  The Lancet Respiratory Medicine · 2014 · 10.1016/s2213-2600(14)70100-6

• Lung Microbiota and Bacterial Abundance in Patients with Bronchiectasis when Clinically Stable and during Exacerbation

  American Journal of Respiratory and Critical Care Medicine · 2013 · https://doi.org/10.1164/rccm.201210-1937oc

• Treatment of lung infection in patients with cystic fibrosis: Current and future strategies

  Journal of Cystic Fibrosis · 2012 · 10.1016/j.jcf.2012.10.004

• The Adult Cystic Fibrosis Airway Microbiota Is Stable over Time and Infection Type, and Highly Resilient to Antibiotic Treatment of Exacerbations

  PLoS ONE · 2012 · 10.1371/journal.pone.0045001

• Recommendations for the classification of diseases as CFTR-related disorders

  Journal of Cystic Fibrosis · 2011 · 10.1016/s1569-1993(11)60014-3

• A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation

  New England Journal of Medicine · 2011 · https://doi.org/10.1056/nejmoa1105185

• Simvastatin Decreases Lipopolysaccharide-induced Pulmonary Inflammation in Healthy Volunteers

  American Journal of Respiratory and Critical Care Medicine · 2009 · 10.1164/rccm.200810-1584oc

• Detection of Anaerobic Bacteria in High Numbers in Sputum from Patients with Cystic Fibrosis

  American Journal of Respiratory and Critical Care Medicine · 2008 · 10.1164/rccm.200708-1151oc

• Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice

  Journal of Cystic Fibrosis · 2008 · 10.1016/j.jcf.2008.03.009

• Standards of care for patients with cystic fibrosis: a European consensus

  Journal of Cystic Fibrosis · 2005 · 10.1016/j.jcf.2004.12.002

• Cystic fibrosis: current survival and population estimates to the year 2000.

  Thorax · 1991 · 10.1136/thx.46.12.881

Current projects

No projects listed.